You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Title |
Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol
|
---|---|
Published in |
Trials, January 2022
|
DOI | 10.1186/s13063-021-05951-w |
Pubmed ID | |
Authors |
Francisco Mera-Cordero, Sara Bonet-Monne, Jesús Almeda-Ortega, Ana García-Sangenís, Oriol Cunillera-Puèrtolas, Sara Contreras-Martos, Gemma Alvarez-Muñoz, Ramon Monfà, Marina Balanzo-Joué, Rosa Morros, Betlem Salvador-Gonzalez |
X Demographics
The data shown below were collected from the profiles of 36 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 12 | 33% |
United States | 3 | 8% |
Mexico | 2 | 6% |
Switzerland | 2 | 6% |
Argentina | 1 | 3% |
Portugal | 1 | 3% |
Unknown | 15 | 42% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 32 | 89% |
Practitioners (doctors, other healthcare professionals) | 4 | 11% |
Mendeley readers
The data shown below were compiled from readership statistics for 119 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 119 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 10 | 8% |
Student > Bachelor | 10 | 8% |
Student > Master | 9 | 8% |
Researcher | 9 | 8% |
Librarian | 6 | 5% |
Other | 16 | 13% |
Unknown | 59 | 50% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 18% |
Nursing and Health Professions | 11 | 9% |
Social Sciences | 5 | 4% |
Computer Science | 3 | 3% |
Psychology | 3 | 3% |
Other | 12 | 10% |
Unknown | 64 | 54% |